Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Schellens

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cephalalgia : an International Journal of Headache|June 26, 2001
Treatment of migraine attacks with intranasal alniditan: an open studyH C Diener, P Louis, R Schellens, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 22, 1987
[Hyponatremia caused by psychogenic polydipsia: a severe pathological condition]J P ter Bruggen, J B ten Holter, R Schellens, et al.
Human Genetics|July 31, 2021
Genetics, pathogenesis and therapeutic developments for Usher syndrome type 2M Stemerdink, B García-Bohórquez, R Schellens, et al.
Cephalalgia : an International Journal of Headache|November 1, 1996
Alniditan in the acute treatment of migraine attacks: a subcutaneous dose-finding study. Subcutaneous Alniditan Study GroupJ Goldstein, C G Dahlöf, H C Diener, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cephalalgia : an International Journal of Headache|June 26, 2001
Treatment of migraine attacks with intranasal alniditan: an open studyH C Diener, P Louis, R Schellens, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 22, 1987
[Hyponatremia caused by psychogenic polydipsia: a severe pathological condition]J P ter Bruggen, J B ten Holter, R Schellens, et al.
Human Genetics|July 31, 2021
Genetics, pathogenesis and therapeutic developments for Usher syndrome type 2M Stemerdink, B García-Bohórquez, R Schellens, et al.
Cephalalgia : an International Journal of Headache|November 1, 1996
Alniditan in the acute treatment of migraine attacks: a subcutaneous dose-finding study. Subcutaneous Alniditan Study GroupJ Goldstein, C G Dahlöf, H C Diener, et al.
Pageof 1